首页> 外文期刊>World Allergy Organization Journal >The Impact of a Program for Control of Asthma in a Low-Income Setting
【24h】

The Impact of a Program for Control of Asthma in a Low-Income Setting

机译:在低收入环境中控制哮喘的程序的影响

获取原文
       

摘要

The prevalence of asthma is increasing in developing countries and the burden of uncontrolled asthma affects patients, families, and the health system. This is to summarize, evaluate, and discuss previous reports on the impact of a targeted and comprehensive approach to the most severe cases of asthma in a low-income setting. A Program for Control of Asthma (ProAR) was developed in Salvador, Bahia, Brazil, prioritizing the control of severe asthma. By facilitating referrals from the public health system and providing proper multidisciplinary but simple management including education and medication, for free, the Program enrolled 2385 patients in 4 reference clinics. They are offered regular follow up and discharged back to primary health care only when asthma control can be maintained without requirement of a combination of an inhaled corticosteroid and a long-acting β2 agonist. ProAR has markedly reduced health resource utilization and decreased the rate of hospital admissions because of asthma in the entire City (2.8 million inhabitants) by 74%. Moderate to severe rhinitis was associated with lack of control of asthma. The average income of the families in the ProAR was US$2955 a year, and they spent 29% of all their income attempting to control the severe asthma of one member, a unbearable expenditure for a low-income family. The ProAR was shown to be cost-effective, reducing costs to the public health system (US$387 patient/year) and the families (US$789 patient/year). In a low-income setting of Brazil, an intervention prioritizing the control of severe asthma was feasible, effective, and reduced costs.
机译:在发展中国家,哮喘的患病率正在上升,不受控制的哮喘的负担影响着患者,家庭和卫生系统。这是为了总结,评估和讨论以前针对针对低收入人群中最严重哮喘病例采取针对性综合方法的影响的报告。在巴西巴伊亚州的萨尔瓦多制定了控制哮喘计划(ProAR),将控制严重哮喘列为优先事项。通过促进公共卫生系统的转诊并免费提供包括教育和药物治疗在内的适当的多学科但简单的管理,该计划在4个参考诊所中招募了2385名患者。只有在不需要将吸入性糖皮质激素和长效β2激动剂联合使用就能维持哮喘控制的情况下,他们才能得到定期​​随访,并恢复到初级卫生保健。由于整个城市(280万居民)患有哮喘,ProAR显着降低了医疗资源的利用率,并使住院率降低了74%。中度至重度鼻炎与哮喘控制不足有关。 ProAR中家庭的平均收入为每年2955美元,他们花费了全部收入的29%来控制一名成员的严重哮喘,这对于低收入家庭来说是难以承受的支出。实践证明,ProAR具有成本效益,可以减少公共卫生系统(387美元患者/年)和家庭(789美元患者/年)的费用。在巴西的低收入地区,优先控制重度哮喘的干预措施可行,有效且降低了成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号